Table 2 indicates that there was significant dyslipidemia in NAFLD patients when compared to the healthy, age-matched control group. Table 2 reveals that the examined groups differed significantly in terms of BMI, ALT, and AST. This evidence concerns the gene GPT and metabolic dysfunction-associated steatotic liver disease.